Covered recipient · General Payments record
ELIZABETH CATHERINE PAINE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,249.68
- Reported across 346 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $287.75 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $75.93 | 4 |
| GlaxoSmithKline, LLC. | $56.66 | 4 |
| ABBVIE INC. | $55.10 | 3 |
| Amgen Inc. | $33.64 | 2 |
| SANOFI PASTEUR INC. | $25.14 | 1 |
| Novo Nordisk AS | $23.26 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.44 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105170386 | CMS |
| ABBVIE INC. | $19.11 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105170388 | CMS |
| ABBVIE INC. | $16.55 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105170390 | CMS |
| Amgen Inc. | $17.28 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117345652 | CMS |
| Amgen Inc. | $16.36 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117345654 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.02 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101207090 | CMS |
| GlaxoSmithKline, LLC. | $13.66 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116430601 | CMS |
| GlaxoSmithKline, LLC. | $13.60 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116271496 | CMS |
| GlaxoSmithKline, LLC. | $14.89 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116411633 | CMS |
| GlaxoSmithKline, LLC. | $14.51 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116214870 | CMS |
| Novo Nordisk Inc | $23.26 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096698719 | CMS |
| PFIZER INC. | $21.20 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131676628 | CMS |
| PFIZER INC. | $20.23 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743412 | CMS |
| PFIZER INC. | $14.69 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131190943 | CMS |
| PFIZER INC. | $19.81 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131426930 | CMS |
| SANOFI PASTEUR INC. | $25.14 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128750791 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.